Neither haploinsufficiency nor a complete deletion of both Tsg101 alleles in somatic tissues of genetically engineered mice, such as the mammary epithelium, led to the development of benign neoplasms or cancer [14,57]. The gene discussed is TSG101; the disease is cancer.